Rayzebio, Inc.

  • Market Cap: Small Cap
  • Industry: Biotechnology
  • ISIN: US75525N1072
USD
62.49
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
Share Capital
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
303.96
201.34
146.78
Shareholder's Funds
303.96
201.34
146.78
Minority Interest
0.00
0.00
0.00
Long-Term Borrowings
1.14
1.85
0.76
Secured Loans
1.14
1.85
0.76
Unsecured Loans
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
Other Long Term Liabilities
10.35
8.91
0.16
Long Term Trade Payables
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Total Non-Current Liabilities
10.35
8.91
0.16
Current Liabilities
Trade Payables
2.62
1.13
0.18
Other Current Liabilities
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
Total Current Liabilities
10.46
6.13
1.50
Total Liabilities
324.78
216.38
148.45
ASSETS
Non-Current Assets
0.00
0.00
0.00
Gross Block
26.27
14.04
1.25
Less: Accumulated Depreciation
1.87
0.47
0.01
Less : Impairment of Assets
0.00
0.00
0.00
Net Block
24.39
13.57
1.23
Lease Adjustment
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
Non Current Investments
0.34
0.28
0.14
Long Term Loans & Advances
0.00
0.00
0.00
Other Non Current Assets
0.01
0.10
0.00
Total Non-Current Assets
24.74
13.96
1.37
Current Assets Loans & Advances
Current Investments
167.09
148.60
3.14
Inventories
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
Cash and Bank
129.16
50.57
143.73
Other Current Assets
296.75
199.67
146.87
Short Term Loans and Advances
0.00
0.00
0.00
Total Current Assets
300.04
202.43
147.08
Net Current Assets (Including Current Investments)
289.58
196.29
145.58
Total Current Assets Excluding Current Investments
300.04
202.43
147.08
Miscellaneous Expenses not written off
0.00
0.00
0.00
Total Assets
324.78
216.38
148.45
Contingent Liabilities
0.00
0.00
0.00
Total Debt
1.14
1.85
0.76
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2022 is 16.16% vs 5,468.75% in Dec 2021

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2022 is 79.73% vs 1,003.25% in Dec 2021

stock-summary

Investments

YoY Growth in year ended Dec 2022 is 21.43% vs 100.00% in Dec 2021

stock-summary

Current Assets

YoY Growth in year ended Dec 2022 is 48.22% vs 37.63% in Dec 2021

Compare Balance Sheet Results of Rayzebio, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
303.96
415.84
-111.88
-26.90%
Shareholder's Funds
303.96
415.84
-111.88
-26.90%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
1.14
50.36
-49.22
-97.74%
Secured Loans
1.14
50.36
-49.22
-97.74%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
10.35
26.75
-16.40
-61.31%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
10.35
73.12
-62.77
-85.85%
Current Liabilities
Trade Payables
2.62
12.46
-9.84
-78.97%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
10.46
62.36
-51.90
-83.23%
Total Liabilities
324.78
551.33
-226.55
-41.09%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
26.27
65.94
-39.67
-60.16%
Less: Accumulated Depreciation
1.87
13.40
-11.53
-86.04%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
24.39
52.55
-28.16
-53.59%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.34
1.70
-1.36
-80.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.01
1.20
-1.19
-99.17%
Total Non-Current Assets
24.74
55.45
-30.71
-55.38%
Current Assets Loans & Advances
Current Investments
167.09
372.69
-205.60
-55.17%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
129.16
111.12
18.04
16.23%
Other Current Assets
296.75
487.53
-190.78
-39.13%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
300.04
495.88
-195.84
-39.49%
Net Current Assets (Including Current Investments)
289.58
433.52
-143.94
-33.20%
Total Current Assets Excluding Current Investments
300.04
495.88
-195.84
-39.49%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
324.78
551.33
-226.55
-41.09%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
1.14
50.36
-49.22
-97.74%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Dec 2022

Figures in Million
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 10.35 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 16.16% vs 5,468.75% in Dec 2021

Annual - Fixed Assets
Fixed Assets 24.39 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 79.73% vs 1,003.25% in Dec 2021

Annual - Investments
Investments 0.34 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 21.43% vs 100.00% in Dec 2021

Annual - Current Assets
Current Assets 300.04 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 48.22% vs 37.63% in Dec 2021